MedTrace Logo

Scalp Block: Hemodynamic Stability and Patient Comfort In Craniotomy Patients

NCT03177252 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2020-10-22

No results posted yet for this study

Summary

Making sure the heart rate and or the blood pressure \[called hemodynamic instability\] during surgery is stable, setting up for a rapid postoperative recovery, and ensuring that patients have adequate pain relief are some of the important goals of neurosurgical anesthesia. Scalp block anesthesia \[injection of a numbing agent into the area of the scalp where the incision will be\] together with general anesthesia is used to achieve these goals. There has been some research on whether or not scalp block improves patient recovery and pain management, but the studies have not be large enough to say for certain. This is true even though scalp block is used with almost every patient that is having brain surgery. The investigators propose to determine if scalp block in combination with asleep anesthesia is better than asleep anesthesia alone in patients who are having brain surgery for tumors in the cerebral area of the brain.

Conditions

  • Tumor, Brain
  • Anesthesia, Local

Interventions

DRUG

Lidocaine

-2% lidocaine will be given

DRUG

Sodium chloride

-Normal saline will be given

DRUG

Bupivacaine

-0.5% bupivacaine will be given

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Umeshkumar Athiraman, M.D. · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-09-30
Completion
2021-09-30
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03177252 on ClinicalTrials.gov